Publications by authors named "Natalia Anger"

Claim this Profile
A
Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1.
Joanna Rossowska, Natalia Anger, Katarzyna Wegierek, Agnieszka Szczygieł, Jagoda Mierzejewska

Front Immunol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy.
Joanna Rossowska, Natalia Anger, Agnieszka Szczygieł, Jagoda Mierzejewska, Elżbieta Pajtasz-Piasecka

J Exp Clin Cancer Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells.
Joanna Rossowska, Natalia Anger, Agnieszka Szczygieł, Jagoda Mierzejewska, Elżbieta Pajtasz-Piasecka

Front Immunol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models.
Jagoda Kicielińska, Agnieszka Szczygieł, Joanna Rossowska, Natalia Anger, Katarzyna Kempińska

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide and IL-12-transduced DCs enhance the antitumor activity of tumor antigen-stimulated DCs and reduce Tregs and MDSCs number.
Joanna Rossowska, Elżbieta Pajtasz-Piasecka, Natalia Anger, Justyna Wojas-Turek, Jagoda Kicielińska

J Immunother· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporary elimination of IL-10 enhanced the effectiveness of cyclophosphamide and BMDC-based therapy by decrease of the suppressor activity of MDSCs and activation of antitumour immune response.
Joanna Rossowska, Natalia Anger, Jagoda Kicielińska, Elżbieta Pajtasz-Piasecka, Aleksandra Bielawska-Pohl

Immunobiology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis